Urinary FSP1 Is a Biomarker of Crescentic GN

作者：Iwano Masayuki^*; Yamaguchi Yukinari; Iwamoto Takaaki; Nakatani Kimihiko; Matsui Masaru; Kubo Atsushi; Akai Yasuhiro; Mori Toshio; Saito Yoshihiko

来源：Journal of the American Society of Nephrology, 2012, 23(2): 209-214.

DOI：10.1681/ASN.2011030229

Fibroblast-specific protein 1 (FSP1)-expressing cells accumulate in damaged kidneys, but whether urinary FSP1 could serve as a biomarker of active renal injury is unknown. We measured urinary FSP1 in 147 patients with various types of glomerular disease using ELISA. Patients with crescentic GN, with or without antinuclear cytoplasmic antibody-associated GN, exhibited elevated levels of urinary FSP1. This assay had a sensitivity of 91.7% and a specificity of 90.2% for crescentic GN in this sample of patients. Moreover, we found that urinary FSP1 became undetectable after successful treatment, suggesting the possible use of FSP1 levels to monitor disease activity over time. Urinary FSP1 levels correlated positively with the number of FSP1-positive glomerular cells, predominantly podocytes and cellular crescents, the likely source of urinary FSP1. Even in patients without crescent formation, patients with high levels of urinary FSP1 had large numbers of FSP1-positive podocytes. Taken together, these data suggest the potential use of urinary FSP1 to screen for active and ongoing glomerular damage, such as the formation of cellular crescents.

• 出版日期2012-2